Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation

Rhea-AI Summary

Evogene (Nasdaq: EVGN) announced that Chairman Nir Nimrodi will participate in the company’s upcoming quarterly results Zoom conference call on Tuesday, August 18, 2026, at 9:00 AM Eastern Time (4:00 PM Israel time). The call will be accessible via advance online registration and a replay will be posted on Evogene’s website.

Market Context

Recent event history showed a 19.95% gain after an AI model launch but a -10.55% move after another ...

Analysis

Recent event history showed a 19.95% gain after an AI model launch but a -10.55% move after another AI milestone. For this shareholder dispute update, director Net Buying and low short positioning add relevant context.

Key Figures

Conference Call Date: August 18, 2026 Eastern Time: 9:00 AM ET Israel Time: 4:00 PM Israel time

3 metrics

Conference Call Date August 18, 2026 Upcoming quarterly results call

Eastern Time 9:00 AM ET Conference call start time

Israel Time 4:00 PM Israel time Conference call start time

Historical Context

5 past events · Latest: Jul 30 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 30	results scheduling	Neutral	+1.6%	Second-quarter results release and conference call scheduled for August 18
Jul 22	strategic collaboration	Positive	+2.3%	ELEO collaboration targeted oral PCSK9 pathway inhibitors for cardiovascular diseases
Jul 15	AI model launch	Positive	+19.9%	AgPlenus launched an antifungal potency prediction model for fungicide discovery
Jul 08	AI drug initiative	Positive	-2.5%	Evogene and Tel Aviv University announced an AI-driven drug discovery initiative
Jun 24	AI platform milestone	Positive	-10.6%	Google Cloud collaboration milestone expanded autonomous small-molecule discovery capabilities

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent history was mixed: three announcements were followed by gains, while two positive AI-related announcements were followed by declines.

Key Terms

computational chemistry, generative design, dissident shareholders

3 terms

computational chemistry technical

"a pioneering company in computational chemistry, specializing in the generative design"

Computational chemistry uses computer models and simulations to predict how molecules behave, how they interact, and what chemical reactions they may undergo. For investors, it matters because these virtual experiments can speed up drug discovery, materials design, and cost estimates—like using a wind tunnel for cars—helping companies reduce development time, lower research costs, and de‑risk projects before expensive lab work or clinical trials.

generative design technical

"specializing in the generative design of small molecules for the pharmaceutical"

Generative design is a computer-driven process that takes goals, limits and available materials and produces many possible product shapes and layouts, similar to telling a smart assistant the ingredients you have and getting dozens of recipe options. For investors, it matters because it can cut engineering time, lower manufacturing costs, create lighter or stronger products, and enable faster innovation — all of which can improve margins, shorten time to market and change competitive dynamics.

dissident shareholders regulatory

"the current situation involving certain dissident shareholders"

Shareholders who publicly challenge a company’s management or board and push for specific changes in strategy, governance, leadership, or capital allocation. They act like a group of tenants organizing to force repairs or new rules: using formal tools such as shareholder proposals, proxy fights, or voting campaigns to try to replace directors, change policies, or influence major decisions. Their actions matter to investors because they can prompt boardroom change, affect short‑term share price volatility, and alter a company’s long‑term direction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Zoom conference call scheduled for August 18, 2026, at 9:00 AM ET

REHOVOT, Israel, Aug. 14, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that its Chairman, Nir Nimrodi, will join the Company's upcoming quarterly results conference call on August 18, 2026. 

Mr. Nimrodi will address the current situation involving certain dissident shareholders. Mr. Nimrodi will discuss the Company's perspective on these developments and the potential implications of those dissidents' attempted actions for Evogene and its shareholders. 

The conference call is scheduled for Tuesday, August 18, 2026, at 9:00 AM Eastern Time (4:00 PM Israel time).

To attend the conference, please register in advance: 
https://www.veidan-conferencing.com/evogene

The entire conference will be available online on the Company's website a few days after the call.

About Evogene:

Evogene Ltd. (Nasdaq/TASE: EVGN) is a pioneering company in computational chemistry, specializing in the generative design of small molecules for drug development and ag chemical products. At the core of its technology is ChemPass AI™, a proprietary generative AI designed to explore vast chemical space and generate novel, highly potent small molecules optimized across multiple critical parameters. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products for the pharmaceutical and agricultural industries, driven by the integration of scientific innovation with real-world industry needs.

For more information, please visit www.evogene.com.

Contact 
ir@evogene.com
Tel: +972-8-9311901

View original content to download multimedia:https://www.prnewswire.com/news-releases/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation-302851346.html

SOURCE Evogene

FAQ

When is Evogene (EVGN) holding its next quarterly results conference call in August 2026?

Evogene will hold its next quarterly results conference call on Tuesday, August 18, 2026, at 9:00 AM Eastern Time (4:00 PM Israel time). According to Evogene, the event will be conducted via Zoom and requires advance registration.

Will Evogene Chairman Nir Nimrodi join the EVGN quarterly call on August 18, 2026?

Yes, Chairman Nir Nimrodi will join Evogene’s quarterly results conference call on August 18, 2026. According to Evogene, he will participate alongside management to discuss company matters during the scheduled Zoom event.

How can investors register for Evogene’s (EVGN) quarterly Zoom conference call on August 18, 2026?

Investors can register in advance via the dedicated link https://www.veidan-conferencing.com/evogene. According to Evogene, prior registration is required to attend the Zoom call scheduled for August 18, 2026, at 9:00 AM Eastern Time.

Will a replay of Evogene’s August 18, 2026 quarterly results call be available online?

Yes, a replay of the entire conference will be available on Evogene’s website a few days after the call. According to Evogene, investors who cannot attend live will be able to access the recorded event online.

What time is Evogene’s August 18, 2026 earnings call in Israel time?

Evogene’s quarterly results conference call on August 18, 2026, starts at 4:00 PM Israel time. According to Evogene, this corresponds to 9:00 AM Eastern Time, and the meeting will be held via Zoom after advance registration.